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INTRODUCTION
A key research focus for the discipline of nursing is to develop a
clear understanding of the human response to illness, with an
emphasis on comfort and function as key outcomes [1–4]; in pedi-
atric oncology, this focus extends to both child and family. Integra-
tion of the nursing discipline within cooperative groups conducting
pediatric oncology clinical trials provides unique opportunities to
maximize nursing’s contribution to clinical care, and to pursue
research questions that extend beyond cure of disease to address
important gaps in knowledge surrounding the illness experience,
from diagnosis through survivorship or end-of-life. In this article,
we will highlight key clinical and research contributions of the
nursing discipline to pediatric oncology clinical trials, utilizing
experiences from the Children’s Oncology Group and its legacy
cooperative groups, and will identify critical issues currently facing
pediatric oncology clinical trials nursing.
HISTORICAL PERSPECTIVE OF NURSING IN THE
COOPERATIVE GROUPS
The discipline of nursing has been represented in oncology
cooperative clinical trials groups in North America since the
1970s [5–7] and in Europe since the 1980s [5]. The initial focus
for nursing in the North American pediatric cooperative groups
(Children’s Cancer Group and Pediatric Oncology Group) was on
improving implementation of clinical trials by providing educa-
tion for nurses concerning the care of patients enrolled on proto-
cols, developing protocol-speciﬁc patient education materials, and
contributing nursing expertise to study development, execution,
and evaluation [6]. In particular, nursing contributions greatly
aided study implementation by providing practical recommenda-
tions related to therapy delivery and collection of protocol-
speciﬁed specimens and data [6].
Nursing research evolved within the pediatric cooperative
groups in the 1980s and 1990s, with nurses leading studies to
address issues identiﬁed as high-priority by the discipline, includ-
ing parental understanding of the study consent and randomiza-
tion process [7] and parental caregiver burden [8], as well as
studies addressing issues in late effects [9] and epidemiology
[10]. The merger of the North American pediatric cooperative
groups in 2000 provided an opportunity to align nursing research
more directly with the scientiﬁc mission of the newly formed
Children’s Oncology Group (COG) [4,11]. The organizational
structure for nursing research within the COG was based on a
scholar team model, designed to address the paucity of doctorally
prepared nurses within the cooperative group [4,12]. This model
paired teams of PhD-level nurse scientists (who had limited co-
operative group experience) with masters-level advanced practice
nurses (APNs, who had extensive knowledge of cooperative group
processes, but limited knowledge of the theoretical underpinnings
of research). Each team focused on identiﬁed research priority
areas for the nursing discipline [12], including fatigue [13], cog-
nitive/behavioral/biological outcomes of central nervous system
treatment [14], adolescent/young adult coping/adjustment [15],
self-care/symptom management [16], treatment decision-making
[17], complementary and alternative medicine [18], and end-of-
life care [19]. Implementation of this model resulted in the unan-
ticipated beneﬁt of a signiﬁcant number of APN nurses pursuing
doctoral studies, yielding a core group of primarily PhD-prepared
nurses, who are well-rounded with respect to both the theoretical
and practical aspects of conducting research, and who are now
well-integrated within the cooperative group. This has led to
reﬁnement of the original model beyond the scholar teams to
include experienced researchers, trainees, and others interested
in conducting nursing research within the cooperative group.
Integration of the nursing discipline within cooperative groups
conducting pediatric oncology clinical trials provides unique oppor-
tunities to maximize nursing’s contribution to clinical care, and to
pursue research questions that extend beyond cure of disease to
address important gaps in knowledge surrounding the illness experi-
ence. Key areas of importance to the advancement of the nursing
discipline’s scientiﬁc knowledge are understanding the effective
delivery of patient/family education, and reducing illness-related dis-
tress, both of which are integral to facilitating parental/child coping
with the diagnosis and treatment of childhood cancer, and to promot-
ing resilience and well-being of pediatric oncology patients and their
families. Pediatr Blood Cancer 2013;60:1031–1036.
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CLINICAL INITIATIVES IN COOPERATIVE GROUP
PEDIATRIC ONCOLOGY NURSING
Nursing Role in Facilitating Staging/Stratification and
Delivery of Protocol-Based Treatment
Pediatric oncology nurses are pivotal to the delivery of proto-
col-directed therapy for children, adolescents, and young adults
with cancer enrolled on clinical trials, and nursing’s integral role
on the multidisciplinary team is well recognized. Nurses are
involved at the point of care, and play a key role in educating
patients and families regarding staging and stratiﬁcation proce-
dures, scheduling and carrying out diagnostic procedures, and
assuring accurate and timely collection of specimens critical to
patient staging and stratiﬁcation across biological and therapeutic
protocols. Nurses assume a crucial role in administration of ther-
apeutic agents and supportive care regimens, delivery of nursing
care for patients undergoing surgery and radiation, assessment,
and management of therapy-related complications, and provision
of patient/family education regarding home medication adminis-
tration, symptom management, and self-care.
Nursing Discipline Clinical Initiatives in the
Cooperative Group
Within the COG, the discipline of nursing continues to make
signiﬁcant contributions to clinical trial implementation through
nursing involvement on protocol committees (providing a nursing
perspective during the protocol development process; assuring
availability of a nursing liaison for each protocol to answer ques-
tions from nurses delivering protocol care, and to address clinical
issues that arise during implementation of the trial), by developing
clinical resource guides (including the Pediatric Oncology Pallia-
tive and End-of-Life Care Resource [20] and the Long-Term Fol-
low-Up Program Resource Guide [21]), and by developing and
evaluating educational materials for patients and families (e.g.,
the COG Family Handbook [22], Family Protocol Summaries, and
‘‘Patients and Families’’ content for the COG Public Website
[23]). These activities are supported by an organizational structure
that distributes responsibilities among several key discipline lead-
ers (Fig. 1). Additionally, two priority areas have been identiﬁed
by the nursing discipline to support continued facilitation of clin-
ical trial conduct. These include development of evidence-based
clinical summaries to guide protocol-related nursing care, and the
development and dissemination of instructional programs to en-
hance nurses’ knowledge regarding care of patients participating
in ongoing clinical trials.
Development of Evidence-Based Clinical Summaries.
Principles of evidence-based practice (i.e., use of current best
evidence in making patient care decisions [24]) are now evident
in the setting of cooperative group nursing to address topics of
high priority and relevance to the delivery of protocol-related
nursing care. As a result, concise, clinically focused summaries,
synthesizing the latest evidence from multiple studies [25], are
being developed by nurse-led teams through mentored experien-
ces, to provide guidance for cooperative group nurses regarding
best practices. These summaries will be updated every 5 years, to
assure that recommendations remain aligned with current litera-
ture. Topics addressed are typically not broached in protocols, but
pertinent to the provision of care to patients enrolled on clinical
trials or in long-term follow-up after treatment (e.g., standardiza-
tion of nursing practices related to chemotherapy administration;
effective delivery of patient and family education). These topics
are identiﬁed and prioritized in an iterative process involving the
nursing discipline membership and leadership, and are vetted by
the leadership of other relevant disciplines and focus areas within
the cooperative group, such as hematology/oncology and adoles-
cent/young adult oncology, prior to implementation. Development
of evidence-based clinical summaries in the cooperative group
setting has the potential to promote excellence in protocol-related
nursing practice by standardizing care, reducing undesirable pro-
tocol-related nursing practice variation, and promoting best nurs-
ing practice based on scientiﬁc evidence whenever possible.
Development/Dissemination of Instructional Programs for
Nurses. Providing education for nurses regarding the care of
patients enrolled on protocols has been a priority for nursing since
the discipline’s initial integration into cooperative group clinical
trials 6. Within the COG, the rapid dissemination of pertinent
protocol information to nurses who share the responsibility for
safe and effective administration and monitoring of therapy is
accomplished through the ongoing development of instructional
Fig. 1. Nursing Discipline Organizational Structure within a Cooperative Group.
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programs. These programs address pertinent protocol-related in-
formation, and are developed under the oversight of the nursing
discipline leadership and disseminated to nurses in a variety of
formats, including clinical trial-focused instructional sessions em-
bedded in annual conferences of the pediatric oncology nursing
professional organization (the Association of Pediatric Hematolo-
gy/Oncology Nurses), multimedia educational modules accessible
on a dedicated website, and educational presentations during
nursing sessions held during annual cooperative group meetings.
Additional strategies for dissemination of protocol-related instruc-
tion using web-based technologies (e.g., webinars) are currently
being explored.
RESEARCH IN COOPERATIVE GROUP PEDIATRIC
ONCOLOGY NURSING
Advances in the Field
Nurse-Initiated Studies. Nurse-initiated studies that have been
successfully conducted within the COG over its ﬁrst decade in-
clude an intervention aimed at increasing resilience and quality of
life in adolescents and young adults undergoing hematopoietic
stem cell transplant (ANUR0631; R01NR008583 [26–30]; evalu-
ation of functional status and quality of life in children with
medulloblastoma (ACNS0331) [31]; and comparison of parental
caregiving demands between patients receiving inpatient versus
outpatient methotrexate infusions (ACCL01P3).
Patient-Reported Outcome (PRO) Resource Center. As
cancer survival rates continue to improve, measurement of pa-
tient-reported outcomes (e.g., symptom-related distress, quality of
life, and behavioral outcomes) is increasingly being integrated into
cooperative group clinical trials [32]. Measurement of PRO in pedi-
atrics has lagged behind adult oncology as a result of methodologi-
cal considerations and a paucity of available instrumentation that
take into consideration patient age and developmental status [32,33].
However, progress with PRO instrument development in pediatrics
continues [34], and the nursing discipline has been integrally in-
volved in establishing a bank of validated PRO instruments for use
in pediatric cooperative group research [35]. Instruments considered
for the bank undergo a systematic review by a panel of experts in
order to determine readiness of each instrument for use in pediatric
oncology trials. For instruments determined by the expert panel as
ready for implementation, a comprehensive description and details
regarding the instrument’s psychometric properties, previous appli-
cations, limitations, and administration and scoring guidelines, are
compiled and made available for use by investigators considering
inclusion of PRO measures in protocols under development.
Nursing Research Traineeship Program. Developing the next
generation of researchers committed to addressing the nursing
discipline’s key knowledge gaps within the pediatric cooperative
groups is essential. Within the COG, this issue is being addressed
through a Nursing Research Traineeship program that provides
mentored 2-year research experiences for two pre- or post-doctor-
al researchers every other year through a competitive application
process [36].
Resilience-Focused Framework for COG Nursing
Research
Based on experiences gained by nurse researchers in the co-
operative group over the past decade, an organizing framework
has recently been adopted to deﬁne the scope and sharpen the
focus of nursing research within the COG. This framework, ‘‘Re-
silience in Individuals and Families Affected by Cancer’’ (Fig. 2)
is based on Haase’s Resilience in Illness Model [37]. Resilience is
the ability to manage stressors in order to gain a positive outcome
from a difﬁcult experience [38]. The organizing framework is
grounded in positive health constructs associated with resilience,
such as courage, derived meaning, connectedness, spiritual per-
spective, hope, adaptability, and well-being. The framework also
incorporates additional patient/family characteristics that may in-
ﬂuence health outcomes (e.g., age, developmental level, illness
and treatment-related characteristics, genetics), and depicts the
theoretical and evidence-based relationships that exist between
critical aspects of the patient/family cancer experience, including
negative and positive inﬂuences on well-being. Negative inﬂuen-
ces include risk factors (e.g., illness-related distress, defensive
coping), while positive inﬂuences include protective factors
(e.g., family cohesion, courageous coping).
The ‘‘Resilience in Individuals and Families Affected by Can-
cer’’ framework is aimed at the promotion of resilience and well-
being for the child/adolescent/young adult with cancer and their
family members across the cancer continuum. This framework
will serve to guide the discipline’s development of new knowledge
by focusing emerging research on understanding the ways individu-
als and their families sustain or regain optimal health in the midst of
serious illness, and by grounding that research in positive health
constructs, thus setting the stage for the development and testing of
interventions designed to promote resilience and well-being for
patients and families facing a pediatric cancer diagnosis.
KEY GAPS IN KNOWLEDGE OF IMPORTANCE
TO THE FIELD
Key areas of importance to the advancement of the nursing
discipline’s scientiﬁc knowledge are developing an understanding
Fig. 2. Framework for Nursing Research Adopted by the Children’s
Oncology Group: Resilience in Individuals and Families Affected by
Cancer (based on Haase’s Resilience in Illness Model [37]). Con-
structs represent key areas of inﬂuence on child and family resilience
and well-being (rectangles ¼ negative inﬂuences; circles ¼ positive
inﬂuences; triangle ¼ overall goal for care of children and families
affected by cancer). Symbols depict positive (þ) and negative ()
evidence-based relationships between each area of inﬂuence, based on
current research ﬁndings.
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of the effective delivery of education to the patient/family, and
reducing illness-related distress in children, adolescents, and
young adults with cancer and their family caregivers. Both of
these areas are integral to facilitating parental/child coping with
the diagnosis and treatment of childhood cancer across the cancer
continuum, and to promoting resilience and well-being of pediat-
ric oncology patients and their families.
Understanding the Effective Delivery
of Patient/Family Education
Providing patient/family education is a core responsibility of
pediatric oncology nursing practice [39,40], and has been identiﬁed
as the single most important factor in facilitating parental/child
coping with the diagnosis and treatment of childhood cancer [41].
Over the past decade, much progress has been made in developing
educational materials speciﬁcally for patients and families partici-
pating in pediatric oncology clinical trials. These include the COG
Family Handbook for Children with Cancer (2005 [42]; 2011 [22]),
content for the ‘‘Patients and Families’’ section of the COG public
website (www.childrensoncologygroup.org), Family Protocol Sum-
maries [23], and patient/family educational materials (‘‘Health
Links’’) that accompany the COG Long-Term Follow-Up Guidelines
[43]. These lay educational materials have been developed by pedi-
atric oncology nursing experts who have capitalized on the multi-
disciplinary expertise available within the cooperative group to
reﬁne the content and message delivery. All materials have been
rigorously reviewed (by members of multiple disciplines, including
nursing, hematology/oncology, radiation oncology, patient advo-
cates, and survivorship experts) prior to dissemination. Nevertheless,
to our knowledge, no hypothesis-driven research has been undertak-
en in the ﬁeld of pediatric oncology to formally delineate the
informational needs of patients/families, to describe the demograph-
ic, clinical, and psychosocial factors that affect the uptake of
information, or to identify vulnerable sub-groups at highest risk
for poor uptake of key information, all of which are necessary in
order to develop targeted interventions to improve information up-
take. Therefore, this is a key gap in knowledge and an area ripe for
scientiﬁc inquiry.
Areas of potential focus for cooperative group nursing re-
search that will address knowledge gaps related to delivering
effective patient/family education in pediatric oncology include:
(i) Describing the patient/family informational needs (i.e., under-
standing disease and treatment plan, informed consent/clinical
trials, medication administration, symptom management/self-
care) related to a cancer diagnosis during childhood/adoles-
cence/young adulthood; (ii) Developing educational materials
that address the informational needs of patients and family mem-
bers across the cancer continuum; (iii) Describing demographic,
clinical, and psychosocial factors (e.g., illness trajectory, emotion-
al distress, learning style, literacy, culture, language, message
formatting/delivery) that affect uptake of key information (i.e.,
disease, treatment, and self-care) by patients/families, and identi-
fying vulnerable sub-groups at highest risk for poor uptake of key
information; (iv) Developing targeted interventions to improve
patient/family uptake of key information related to a pediatric
cancer diagnosis; (v) Developing the necessary infrastructure to
standardize and disseminate state-of-the-art patient/family
education materials; and (vi) Describing the impact of increased
patient/family disease-, treatment-, and self-care-related knowl-
edge on resilience and overall quality of life.
Knowledge gained from this work could be used to modify
existing patient/family educational materials, to develop new
materials as needed based on the ﬁndings, to determine the
most effective use of these materials (e.g., method/timing of
delivery [44], literacy level [45], use of technology [46]), and to
develop the necessary cooperative group infrastructure to stan-
dardize and disseminate the materials. Potential trial endpoints
could include disease and treatment-related knowledge, self (or
parent/caregiver-delivered) care performance, patient/family cop-
ing, resilience, and quality of life. Potential opportunities within
this line of research include the development of evidence-based
educational interventions aimed at improving patient/family in-
formation uptake, coping, resilience, and overall quality of life.
Reducing Illness-Related Distress
Management of illness-related distress (physiologic and emo-
tional) is a key domain in pediatric oncology nursing practice [39]
and has been a major focus area for nursing discipline research
within the cooperative group over the past decade. The emerging
ﬁeld of cancer symptom science is also an area of high priority for
the National Institute for Nursing Research, and the National
Cancer Advisory Board has called for a signiﬁcant increase in
symptom-directed research [47]. Emerging methods include eval-
uation of patterns of treatment-related symptoms, genetic variance
in cytokines and its relation with key symptoms, and the relation-
ship between symptoms, cytokines, and neurotransmitters, which
contribute to the understanding of factors (patient-treatment-
environment) that may facilitate or inhibit symptom expression
[48]. Several nurse researchers within the COG have expertise in
symptom science, and many have conducted studies applicable to
this domain [49–66]. Because symptoms are subjective in nature,
incorporation of validated tools assessing patient-reported out-
comes is a critical component of this work [33,35].
Currently, the nursing discipline within the COG is conducting
an interventional trial (ANUR1131) aimed at reducing illness-
related distress in adolescents and young adults with high-risk
cancers and high potential for illness-related distress (including
symptom distress). Additional areas of focus that will address
knowledge gaps related to illness-related distress include: (i) De-
scribing the symptoms (fatigue, pain, nausea, anxiety, depression,
cognitive compromise) experienced by children/adolescents/
young adults undergoing treatment for cancer; (ii) Understanding
the host, clinical, and biological basis for the symptoms experi-
enced by children/adolescents/young adults undergoing treatment
for cancer, and identifying vulnerable sub-groups at highest risk
for symptom-related distress; (iii) Describing the impact of symp-
toms on resilience and overall quality of life; (iv) Describing the
caregiver burden and distress experienced by the parents of chil-
dren/adolescents/young adults undergoing treatment for cancer;
(v) Developing targeted interventions to reduce symptoms,
improve functional status, and promote resilience/overall well-
being of children, adolescents, and young adults undergoing
treatment for cancer and their families; and (vi) Developing the
necessary cooperative group infrastructure to standardize the
collection of patient-reported outcomes in order to describe, un-
derstand, and address illness-related distress.
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Knowledge gained from this work could be used to identify
vulnerable populations at high risk for symptom-related distress
and to develop evidence-based interventions to prevent or allevi-
ate treatment-related symptoms in those at highest risk; there are
also signiﬁcant opportunities for inclusion of PROs in symptom-
focused trials. Advances in ameliorating symptom-related distress
hold promise for the promotion of resilience and well-being for
the child/adolescent/young adult with cancer and their family
members across the cancer continuum.
CHALLENGES AND OPPORTUNITIES FOR NURSING
WITHIN THE COOPERATIVE GROUPS
The focal point for nursing research and practice remains the
human experience of and response to illness; this differs signiﬁ-
cantly from the survival-focused paradigm driving most coopera-
tive group clinical trial endpoints. Yet, as differences in survival
between treatment regimens continue to narrow, quality of survival
is emerging as an important outcome across disciplines [67,68].
Thus, the nursing discipline is poised now more than ever to
contribute its expertise toward exploring trial endpoints beyond
survival, including reduction in illness-related distress, understand-
ing delivery of effective patient/family education, and promotion of
resilience for patients and families facing childhood cancer. Execu-
tion of these nursing research objectives is facilitated by the unique
opportunities available within the cooperative group, including
access to large and similarly treated pediatric oncology patient
populations, a biospecimen repository annotated with known treat-
ment exposures at speciﬁc time points, and an infrastructure that
facilitates data collection, protocol implementation, and close in-
terdisciplinary collaboration. The discipline of nursing is thus well-
positioned to continue to play a crucial role in implementation of
pediatric cooperative group clinical trials, and to address gaps in
scientiﬁc knowledge that will lead to an increased understanding of
the amelioration of illness-related distress and the promotion of
illness-related knowledge and self-care.
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